中性粒细胞与淋巴细胞比值在头颈癌中的预后作用:一项荟萃分析
结果显示,NLR高于 cutoff 值与较差的总生存期(HR 1.69;95% CI 1.47-1.93;P < .001)和疾病特异性生存期(HR 1.88;95% CI 1.20-2.95;P = .006)相关。结论认为升高的NLR预测HNSCC患者不良结局。
要点
- 治疗前NLR升高与HNSCC患者总生存期和疾病特异性生存期较差独立相关。
- NLR高于 cutoff 值时,总生存期风险比HR为1.69(95% CI 1.47-1.93;P < .001)。
- NLR高于 cutoff 值时,疾病特异性生存期风险比HR为1.88(95% CI 1.20-2.95;P = .006)。
核心结论
- 治疗前NLR升高预测头颈鳞状细胞癌患者总生存期和疾病特异性生存期更差。
研究设计与样本
- 提取风险比(HR)和95%置信区间(CI),采用随机效应模型合并总生存期和疾病特异性生存期的HR。
主要发现
- NLR高于 cutoff 值与较差总生存期相关(HR 1.69;95% CI 1.47-1.93;P < .001)。
- NLR高于 cutoff 值与较差疾病特异性生存期相关(HR 1.88;95% CI 1.20-2.95;P = .006)。
关键数值与推荐
- 总生存期合并HR为1.69(95% CI 1.47-1.93;P < .001),对应NLR高于 cutoff 值。
- 疾病特异性生存期合并HR为1.88(95% CI 1.20-2.95;P = .006),对应NLR高于 cutoff 值。
临床怎么用
- 治疗前NLR可作为HNSCC患者预后风险评估的参考指标。
- NLR高于 cutoff 值提示预后较差,可辅助临床决策和分层管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neutrophils play substantial roles in cancer progression. Previous reports demonstrated the prognostic impact of the pretreatment neutrophil-to-lymphocyte ratio (NLR) in various types of solid cancers. The purpose of this study was to quantify the prognostic impact of NLR on head and neck squamous cell carcinoma (HNSCC). METHODS: We systematically searched electronic databases, identified articles regarding NLR and HNSCC mortality, and extracted hazard ratios (HRs) and 95% confidence intervals (CIs). Pooled HRs for overall survival (OS) and disease-specific survival (DSS) were estimated using random effect models. RESULTS: Nineteen studies enrolling 3770 patients were included in the analyses. Overall, NLR greater than the cutoff value was associated with poorer OS and DSS (HR 1.69; 95% CI 1.47-1.93; P < .001 and HR 1.88; 95% CI 1.20-2.95; P = .006, respectively). CONCLUSION: Elevated NLR predicts worse outcomes in patients with HNSCC.
引用
- Takenaka Y, Oya R, Kitamiura T, et al. Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis. Head Neck. 2017. PMID: 29076207. doi:10.1002/hed.24986
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。